Skip to content

Evaluation of the effect of the arm basilic vein transposition in brachiobasilic arteriovenous fistulas dialysability in chronic renal failure

Evaluation of the effect of the arm basilic vein transposition in brachiobasilic arteriovenous fistulas dialysability in chronic renal failure

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT2014110716473N3
Enrollment
30
Registered
2014-11-09
Start date
2014-09-23
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic kidney disease. Chronic kidney disease, stage 5

Interventions

transposition (superficialization and lateralization) of arm basilic vein.
Treatment - Surgery
transposition (superficialization and lateralization) of arm basilic vein

Sponsors

Research vice-chancellor of Tabriz University of medical sciences
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Inclusion criteria: Brachiobasilic arteriovenous fistula for hemodialysis; minimum venous flow of 400 ml per minute; minimum venous diameter of 6 mm; no arterial steal syndrome; no venous hypertension; no significant skin lesion in the arm region; at least 2 months interval after the surgery; failure to access by the most experienced dialysis nurse at least for 3 times. Exclusion criteria: venous flow less than 400 ml per minute; venous diameter less than 6 mm; fibrous changes of proximal basilic vein; less than 10 cm of releasable vein because of every reason; venous hypertension; steal syndrome; deformity of the arm; significant chronic or infectious skin lesion in the arm region; death in the follow-up period before the first dialysis attempt

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Dialysability. Timepoint: 45 days after the surgery. Method of measurement: By the dialysis nurse.;Basilic vein blood flow difference. Timepoint: before and 45 days after the surgery. Method of measurement: by doppler sonography.;Basilic vein diameter difference. Timepoint: before and 45 days after the surgery. Method of measurement: by doppler sonography.;Length of releasable basilic vein. Timepoint: intraoperative finding. Method of measurement: by a ruler in centimeter.;Maximum distance of basilic vein thrill from the skin incision. Timepoint: 45 days after the surgery. Method of measurement: by a ruler in centimeter.

Secondary

MeasureTime frame
Patient's age. Timepoint: before the operation. Method of measurement: in years.;Patient's gender. Timepoint: before the operation. Method of measurement: male or female.;Cause of renal failure. Timepoint: before the operation. Method of measurement: by questionairre.;Duration of the disease. Timepoint: before the operation. Method of measurement: by questionnaire in months.;Circumference of the midforearm. Timepoint: before and 45 days after the operation. Method of measurement: with a tape in centimeter.;Arterial steal syndrome. Timepoint: 45 days after the operation. Method of measurement: by the surgeon according to history and physical exam.;Venous hypertension. Timepoint: 45 days after the operation. Method of measurement: by the surgeon according to history and physical exam.;Bleeding. Timepoint: 24 hours after the operation. Method of measurement: by the surgeon according to history and physical exam.;Hematoma. Timepoint: 24 hours after the operation. Method of measurement: by the surgeon according to history and physical exam.;Wound infection. Timepoint: 1,7,14 days after the operation. Method of measurement: by the surgeon according to history and physical exam.;Nerve injury. Timepoint: 1,7,14 days after the operation. Method of measurement: by the surgeon according to history and physical exam.;Distal neuropathy. Timepoint: 1,7,14 days after the operation. Method of measurement: by the surgeon according to history and physical exam.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactFarzad Kakaei

Tabriz University of medical sciences

fkakaei@yahoo.com+98 41 3334 1317

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026